136 related articles for article (PubMed ID: 15801858)
1. Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand.
Tatsumi R; Fujio M; Satoh H; Katayama J; Takanashi S; Hashimoto K; Tanaka H
J Med Chem; 2005 Apr; 48(7):2678-86. PubMed ID: 15801858
[TBL] [Abstract][Full Text] [Related]
2. (R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.
Tatsumi R; Fujio M; Takanashi S; Numata A; Katayama J; Satoh H; Shiigi Y; Maeda J; Kuriyama M; Horikawa T; Murozono T; Hashimoto K; Tanaka H
J Med Chem; 2006 Jul; 49(14):4374-83. PubMed ID: 16821797
[TBL] [Abstract][Full Text] [Related]
3. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.
Bodnar AL; Cortes-Burgos LA; Cook KK; Dinh DM; Groppi VE; Hajos M; Higdon NR; Hoffmann WE; Hurst RS; Myers JK; Rogers BN; Wall TM; Wolfe ML; Wong E
J Med Chem; 2005 Feb; 48(4):905-8. PubMed ID: 15715459
[TBL] [Abstract][Full Text] [Related]
4. Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.
Wishka DG; Walker DP; Yates KM; Reitz SC; Jia S; Myers JK; Olson KL; Jacobsen EJ; Wolfe ML; Groppi VE; Hanchar AJ; Thornburgh BA; Cortes-Burgos LA; Wong EH; Staton BA; Raub TJ; Higdon NR; Wall TM; Hurst RS; Walters RR; Hoffmann WE; Hajos M; Franklin S; Carey G; Gold LH; Cook KK; Sands SB; Zhao SX; Soglia JR; Kalgutkar AS; Arneric SP; Rogers BN
J Med Chem; 2006 Jul; 49(14):4425-36. PubMed ID: 16821801
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.
O'Donnell CJ; Rogers BN; Bronk BS; Bryce DK; Coe JW; Cook KK; Duplantier AJ; Evrard E; Hajós M; Hoffmann WE; Hurst RS; Maklad N; Mather RJ; McLean S; Nedza FM; O'Neill BT; Peng L; Qian W; Rottas MM; Sands SB; Schmidt AW; Shrikhande AV; Spracklin DK; Wong DF; Zhang A; Zhang L
J Med Chem; 2010 Feb; 53(3):1222-37. PubMed ID: 20043678
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists.
Walker DP; Wishka DG; Piotrowski DW; Jia S; Reitz SC; Yates KM; Myers JK; Vetman TN; Margolis BJ; Jacobsen EJ; Acker BA; Groppi VE; Wolfe ML; Thornburgh BA; Tinholt PM; Cortes-Burgos LA; Walters RR; Hester MR; Seest EP; Dolak LA; Han F; Olson BA; Fitzgerald L; Staton BA; Raub TJ; Hajos M; Hoffmann WE; Li KS; Higdon NR; Wall TM; Hurst RS; Wong EH; Rogers BN
Bioorg Med Chem; 2006 Dec; 14(24):8219-48. PubMed ID: 17011782
[TBL] [Abstract][Full Text] [Related]
7. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
[TBL] [Abstract][Full Text] [Related]
8. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist.
Feuerbach D; Nozulak J; Lingenhoehl K; McAllister K; Hoyer D
Neurosci Lett; 2007 Apr; 416(1):61-5. PubMed ID: 17314009
[TBL] [Abstract][Full Text] [Related]
9. (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor.
Mullen G; Napier J; Balestra M; DeCory T; Hale G; Macor J; Mack R; Loch J; Wu E; Kover A; Verhoest P; Sampognaro A; Phillips E; Zhu Y; Murray R; Griffith R; Blosser J; Gurley D; Machulskis A; Zongrone J; Rosen A; Gordon J
J Med Chem; 2000 Nov; 43(22):4045-50. PubMed ID: 11063601
[TBL] [Abstract][Full Text] [Related]
10. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.
Feuerbach D; Lingenhoehl K; Olpe HR; Vassout A; Gentsch C; Chaperon F; Nozulak J; Enz A; Bilbe G; McAllister K; Hoyer D
Neuropharmacology; 2009 Jan; 56(1):254-63. PubMed ID: 18793655
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligands.
Li T; Bunnelle WH; Ryther KB; Anderson DJ; Malysz J; Helfrich R; Grønlien JH; Håkerud M; Peters D; Schrimpf MR; Gopalakrishnan M; Ji J
Bioorg Med Chem Lett; 2010 Jun; 20(12):3636-9. PubMed ID: 20472430
[TBL] [Abstract][Full Text] [Related]
12. Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity.
Acker BA; Jacobsen EJ; Rogers BN; Wishka DG; Reitz SC; Piotrowski DW; Myers JK; Wolfe ML; Groppi VE; Thornburgh BA; Tinholt PM; Walters RR; Olson BA; Fitzgerald L; Staton BA; Raub TJ; Krause M; Li KS; Hoffmann WE; Hajos M; Hurst RS; Walker DP
Bioorg Med Chem Lett; 2008 Jun; 18(12):3611-5. PubMed ID: 18490160
[TBL] [Abstract][Full Text] [Related]
13. 2-(Arylmethyl)-3-substituted quinuclidines as selective alpha 7 nicotinic receptor ligands.
Mazurov A; Klucik J; Miao L; Phillips TY; Seamans A; Schmitt JD; Hauser TA; Johnson RT; Miller C
Bioorg Med Chem Lett; 2005 Apr; 15(8):2073-7. PubMed ID: 15808471
[TBL] [Abstract][Full Text] [Related]
14. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Δ2-isoxazoline derivatives as potent and selective agonists of α7 nicotinic acetylcholine receptors.
Dallanoce C; Magrone P; Matera C; Frigerio F; Grazioso G; De Amici M; Fucile S; Piccari V; Frydenvang K; Pucci L; Gotti C; Clementi F; De Micheli C
ChemMedChem; 2011 May; 6(5):889-903. PubMed ID: 21365765
[TBL] [Abstract][Full Text] [Related]
16. High affinity ligands for the alpha7 nicotinic receptor that show no cross-reactivity with the 5-HT3 receptor.
Baker SR; Boot J; Brunavs M; Dobson D; Green R; Hayhurst L; Keenan M; Wallace L
Bioorg Med Chem Lett; 2005 Nov; 15(21):4727-30. PubMed ID: 16165358
[TBL] [Abstract][Full Text] [Related]
17. Octahydropyrrolo[3,4-c]pyrrole: a diamine scaffold for construction of either alpha4beta2 or alpha7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity.
Bunnelle WH; Tietje KR; Frost JM; Peters D; Ji J; Li T; Scanio MJ; Shi L; Anderson DJ; Dyhring T; Grønlien JH; Ween H; Thorin-Hagene K; Meyer MD
J Med Chem; 2009 Jul; 52(14):4126-41. PubMed ID: 19552432
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of [125I]I-TSA as a brain nicotinic acetylcholine receptor alpha7 subtype imaging agent.
Ogawa M; Tatsumi R; Fujio M; Katayama J; Magata Y
Nucl Med Biol; 2006 Apr; 33(3):311-6. PubMed ID: 16631079
[TBL] [Abstract][Full Text] [Related]
19. Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).
Ghiron C; Haydar SN; Aschmies S; Bothmann H; Castaldo C; Cocconcelli G; Comery TA; Di L; Dunlop J; Lock T; Kramer A; Kowal D; Jow F; Grauer S; Harrison B; La Rosa S; Maccari L; Marquis KL; Micco I; Nencini A; Quinn J; Robichaud AJ; Roncarati R; Scali C; Terstappen GC; Turlizzi E; Valacchi M; Varrone M; Zanaletti R; Zanelli U
J Med Chem; 2010 Jun; 53(11):4379-89. PubMed ID: 20465311
[TBL] [Abstract][Full Text] [Related]
20. Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
Abreo MA; Lin NH; Garvey DS; Gunn DE; Hettinger AM; Wasicak JT; Pavlik PA; Martin YC; Donnelly-roberts DL; Anderson DJ; Sullivan JP; Williams M; Arneric SP; Holladay MW
J Med Chem; 1996 Feb; 39(4):817-25. PubMed ID: 8632405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
